Carcinoma, Non-Small-Cell Lung: all 6,641 studies
Page 57 of 67. Open to participants first (1,665), then studies with results posted, then the rest; newest registration first within each.
- Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing ChemoradiationWithdrawnNCT01314677Not applicable
- Iressa for EGFR Mutation Negative Non-small Cell Lung Cancer (NSCLC)Status unknownNCT01312337Phase 2
- MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLCCompletedNCT01310244Phase 1/2
- Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung CancerStatus unknownNCT01305967Phase 2
- Quality of Life Comparison in Advanced Non-squamous Non Small Cell Lung CancerStatus unknownNCT01303926Phase 3
- Chemotherapy With or Without Radiosurgery for Asymptomatic Oligo Brain MetastasisStatus unknownNCT01301560Phase 3
- Molecular Determinants of Acquired Clinical Resistance to Crizotinib in Non-small Cell Lung Cancer Harboring a Translocation or Inversion Event Involving the ALK Gene LocusCompletedNCT01300429
- Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant ChemotherapyTemporarily not availableNCT01297101
- Chemotherapy for Lung Cancer in HIV-positive PatientsCompletedNCT01296113Phase 2
- Biomarkers in Predicting Response in Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant ChemotherapyCompletedNCT01294280
- Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung CancerStatus unknownNCT01287962Phase 3
- Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC)CompletedNCT01282450Phase 2
- Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLCCompletedNCT01282437Phase 3
- Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung CancerTerminatedNCT01282333Phase 1
- TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung CancerTerminatedNCT01282151Phase 3
- Expanded Access Multicenter Study of Lucanix® (Belagenpumatucel-L)No longer availableNCT01279798
- Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC)CompletedNCT01279408
- Minimally Invasive or Open Surgery for Lung Cancer: Pain, Quality of Life and Economics.CompletedNCT01278888Not applicable
- A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung CancerCompletedNCT01270386Phase 2
- Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung CancerCompletedNCT01263886Phase 2
- Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RTCompletedNCT01261585
- Clinical Study of Microdosing Carboplatin in Lung or Bladder CancerTerminatedNCT01261299Early Phase 1
- An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and RadiationStatus unknownNCT01260480Phase 2
- Study in NSCLC: is Timely Analysis of EGFR-mutation Status Feasible in Region Antwerp, Belgium.CompletedNCT01260038
- Pemetrexed/Carboplatin vs Vinorelbine/Carboplatin in Patients With Completely Resected Non-small Cell Lung Cancer (NSCLC)Status unknownNCT01258127
- Trial Involving Subjects Over 70 Years of Age With Non Small-cell Lung Cancer of Stage IV and Comparing a "Classical" Strategy of Treatment Allocation, With an"Optimized" Strategy Allocating the Same TreatmentsCompletedNCT01257139Phase 3
- Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung CancerCompletedNCT01255150
- A Study of ARQ 197 in Combination With ErlotinibCompletedNCT01251796Phase 1
- Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionTerminatedNCT01249443Phase 1
- Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With MalignanciesCompletedNCT01242072Phase 1
- Immunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer PatientsCompletedNCT01240447Phase 2
- Association Between VEGF-C and miRNA and Clinical Non-small Cell Lung Cancer and Esophagus Squamous Cell CarcinomaStatus unknownNCT01240369
- A Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage Non Small Cell Lung CancerWithdrawnNCT01237171
- Nab-Paclitaxel Treatment in Advanced Squamous Cell Carcinoma of LungCompletedNCT01236716Phase 2
- Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and PaclitaxelCompletedNCT01234038Phase 1/2
- A Study of Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01225302Phase 1
- Study for Therapy of Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) With Cisplatin / Docetaxel or Oxaliplatin / DocetaxelCompletedNCT01222312Phase 2
- TF2- Small Cell Lung Cancer Radio ImmunotherapyCompletedNCT01221675Phase 1/2
- Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) GeneCompletedNCT01221077Phase 2
- Erlotinib as Neoadjuvant Treatment in Patients With Stage ⅢA N2 NSCLC With Activating EGFR Mutation.CompletedNCT01217619Phase 2
- Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC)Status unknownNCT01211002Phase 4
- Nitroglycerin in Non-small Cell Lung CancerTerminatedNCT01210378Phase 2
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerStatus unknownNCT01210053Phase 2
- LUX Lung Special Access Scheme Australia Named Patient Use (NPU)Approved for marketingNCT01209650
- Adaptive Radiotherapy in Non-small Cell Lung Cancer (NSCLC)CompletedNCT01207063Phase 2
- Pre-Operative Assessment of Chest Wall Invasion in NSCLC Using Pre-Operative, Surgeon Performed UltrasoundCompletedNCT01206894Not applicable
- Influence of Prior Chemotherapy on Clinical Benefit With Erlotinib in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer With or Without EGFR Gene MutationCompletedNCT01204307Phase 2
- Study of PX-866 and Docetaxel in Solid TumorsCompletedNCT01204099Phase 1/2
- Valproic Acid With Chemoradiotherapy for Non-Small-Cell Lung CancerStatus unknownNCT01203735Phase 1/2
- Study to Investigate Bronchial Arterrial Infusing (BAI) Plus Three-dimensional Conformal Radiotherapy (3DCRT) in Local Advanced Non-small Cell Lung Cancer (NSCLC)Status unknownNCT01201044Not applicable
- Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung CancerCompletedNCT01196234Phase 2
- An Observational Study of Tarceva (Erlotinib) in Routine Practice For First Line Maintenance Therapy in Patients With Non Small Cell Lung CancerCompletedNCT01194050
- Pemetrexed in Advanced Non-small Cell Lung CancerCompletedNCT01193959
- RO4929097 and Erlotinib Hydrochloride in Treating Patients With Stage IV or Recurrent Non-small Cell Lung CancerTerminatedNCT01193881Phase 1
- Development of Circulating Tumour Cell Molecular Diagnostics Using a Novel Microfluidic DeviceStatus unknownNCT01193829
- Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer PatientsStatus unknownNCT01192243Phase 2
- Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer PatientsStatus unknownNCT01192230Phase 2
- A Study of Carboplatin and Pemetrexed Plus Demcizumab (OMP-21M18) in Subjects With Non-Squamous Non-Small Cell Lung CancerCompletedNCT01189968Phase 1
- A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung CancerTerminatedNCT01188707Phase 1/2
- Pulmonary Interstitial Lymphography in Early Stage Lung CancerTerminatedNCT01188486Not applicable
- Determination of Safety, Efficacy, and Pharmacokinetics of "Regorafenib" Combined With Pemetrexed and Cisplatin in Patients With Nonsquamous Non-Small Cell Lung CancerTerminatedNCT01187615Phase 1
- Preoperative Chemoradiotherapy Versus Chemotherapy Alone in Nonsmall Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node MetastasesStatus unknownNCT01187290Phase 2
- Phase 2 Study of Maintenance OSI-906 Plus Erlotinib (Tarceva®), or Placebo Plus Erlotinib in Patients With Nonprogression Following 4 Cycles of Platinum-based ChemotherapyCompletedNCT01186861Phase 2
- A Study of RO5083945 in Combination With Chemotherapy Versus Chemotherapy Alone in Patients With Advanced or Recurrent Non-Small Cell Lung CancerCompletedNCT01185847Phase 2
- To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT01185314Not applicable
- A Study Of Ranpirnase(Onconase®) To Pemetrexed Plus Carboplatin In Patients With Non-Squamous Non-Small Cell Lung CancerWithdrawnNCT01184287Phase 2
- Pazopanib and Paclitaxel for Non-Small Cell Lung CancerWithdrawnNCT01179269Phase 2
- Palliative 3-Dimensional Conformal Radiation Therapy in Reducing Radiation Side Effects in Patients With Lung Cancer. ICORG 06-34CompletedNCT01176487Not applicable
- Effects of Essential Amino Acid Intake on Net Protein Synthesis in Weight-losing Non-small Cell Lung Cancer PatientsCompletedNCT01172314Not applicable
- Paclitaxel-Carboplatin-Bevacizumab +/- Nitroglycerin in Metastatic Non-Squamous-Non-Small Cell Lung CancerCompletedNCT01171170Phase 2
- FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung CancerStatus unknownNCT01170923Phase 2
- Observational Study on the Management of Patients With Non Small Cell Lung Cancer AdenocarcinomaCompletedNCT01167972
- Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung CancerCompletedNCT01167530Phase 1
- Trial of BMS-690514 in Non-Small Cell Lung Cancer Subjects Who Have Been Treated With Gefitinib or Erlotinib and Are Genotypically EGFR Mutation Positive or Who Have Had a Prior ResponseCompletedNCT01167244Phase 2
- Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone With Intensity-modulated Radiotherapy (IMRT) for Non Small Cell Lung Cancer (NSCLC) to an Individualised Mean Lung Dose (MLD)CompletedNCT01166204Phase 2
- Study of Hypofractionated Proton Radiation Therapy in Thoracic MalignanciesTerminatedNCT01165658Phase 1
- Tyrosine Kinase Inhibitors In Metastatic Non Small Cell Lung CancerStatus unknownNCT01163058
- Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung CancerCompletedNCT01160601Phase 2
- Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by SurgeryTerminatedNCT01159964Phase 1
- Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived ExosomesCompletedNCT01159288Phase 2
- Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)Status unknownNCT01158170Phase 3
- Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)Status unknownNCT01158144Phase 2
- Endobronchial Ultrasound Guided Transbronchial Aspiration (EBUS-TBNA) in Non Small Cell Lung Cancer (NSCLC) in a Tuberculosis-endemic CountryCompletedNCT01156623Not applicable
- BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLCCompletedNCT01156545Phase 2
- Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT01155258Phase 1
- A Non-interventional Study (NIS) Registry for the Epidemiological and Scientific Evaluation of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) (Stage IIIB/IV Non-small Cell Lung Cancer).CompletedNCT01153399
- Dose Defining Study For MK-2206 Combined With Gefitinib In Non Small Cell Lung Cancer (NSCLC)Status unknownNCT01147211Phase 1
- MEK Inhibitor and Thoracic Radiotherapy TrialCompletedNCT01146756Phase 1
- Utility of Routine Cervical Mediastinoscopy in Clinical Stage I Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01146366
- Biomarkers in Tissue and Blood Samples From Patients With Early-Stage Non-Small Cell Lung CancerCompletedNCT01139944
- A Retrospective Study to Investigate the Current Situation of Biopsy Testing in Swedish Inoperable Non Small Cell Lung Cancer (NSCLC) PatientsCompletedNCT01139619
- Prediction of the Effectiveness of Hypofractionated Radiation Therapy in Early Stage Lung Cancer by Bio-imaging and BiomarkersTerminatedNCT01138748Phase 2
- Predicting Cell Death by Radiation Therapy in Early Stage Non-small Cell Lung Cancer: a Prospective Translational TrialTerminatedNCT01138722Phase 2
- Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung CancerCompletedNCT01138163Phase 2
- Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)CompletedNCT01137968Phase 2
- Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR InhibitorsTerminatedNCT01137162
- Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung CancerCompletedNCT01134861Phase 3
- Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour PatientsCompletedNCT01134250Phase 1/2
- A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR MutationsStatus unknownNCT01131429Phase 2
- Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsCompletedNCT01131234Phase 1